Covestor’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding LXRX
AG
SL
Covestor's LXRX Position: Q3 2026 in Review
Covestor increased its Lexicon Pharmaceuticals (LXRX) stake by 127% in Q3 2026, buying an estimated $230 and bringing the position to 184 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2633.
Covestor first reported a position in LXRX in Q2 2023 and has held it in 14 quarters since. The position peaked at $19K in Q2 2023. 155 funds tracked by Wall St. Rank hold LXRX as of Q3 2026.
- Covestor held 184 shares of Lexicon Pharmaceuticals worth $0 as of Q3 2026.
- Covestor bought 103 Lexicon Pharmaceuticals shares in Q3 2026, an estimated $230.
- Lexicon Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2633 holding.
- Covestor first reported a position in Lexicon Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
- Covestor's Lexicon Pharmaceuticals position peaked at $19K in Q2 2023.
- 155 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.